This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma t…

Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation

~Estimated

~$75 – $2,000

Actual pay is set by the research site.

Alliance for Clinical Trials in OncologyNCT02523014

Phase 2

MOMENTUM-1: A Multicenter, Randomized, Open-Label, Phase II Study of [177LU]LU-DOTATATE in Adults With Progressive Intracranial Grade 1-3 Meningioma

This is an open-label, multicenter, randomized, phase 2 clinical study to evaluate the efficacy of \[177Lu\]Lu-DOTATATE in patients with progressive grade 1-3 …

Intracranial Meningioma

~Estimated

~$75 – $2,000

Actual pay is set by the research site.

RTOG Foundation, Inc.NCT06955169